Outset Medical Posts 78-Cent Quarterly Loss Per Share
OM sits 56% above its 52-week low of $2.841.
Summary
Outset Medical reported a third-quarter loss of 78 cents per share, per Dow Jones Newswires, with a quarterly loss of $14.7M. Revenue for the quarter rose 14% to $33.6M. That follows a Q2 where the company narrowed its net loss and improved gross margin but still posted declining year-to-date revenue, so the bottom line remains the story. For a company this small, a loss of that size is a meaningful hit to book value and keeps the pressure on cash burn. The stock trades near $4.44, leaving little cushion if the loss came with weak revenue or another cash draw. Watch for the full release and any guidance update, plus the next 10-Q for cash and liquidity detail.
At the time of this announcement, OM was trading at $4.44 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $83.6M. The 52-week trading range was $2.84 to $12.97. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.